13F HOLDINGS REPORT
GENERAL ATLANTIC, L.P.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950142-24-001354
Total Value
$4.31B
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DLOCAL | DLO | 63,906,695 | $939.4M | 21.82% |
| 2 | XP, INC | XP | 29,617,733 | $760.0M | 17.65% |
| 3 | ALKAMI | ALKT | 18,729,806 | $460.2M | 10.69% |
| 4 | HIRERIGHT | 433537107 | 32,109,898 | $458.2M | 10.64% |
| 5 | SQUARESPACE | 85225A107 | 10,611,073 | $386.7M | 8.98% |
| 6 | ALIGNMENT HEALTHCARE | ALHC | 60,993,323 | $302.5M | 7.03% |
| 7 | PHARVARIS | PHVS | 7,531,252 | $174.0M | 4.04% |
| 8 | EUROPEAN WAX CENTER | 29882P106 | 13,110,492 | $170.2M | 3.95% |
| 9 | AKERO THERAPEUTICS | 00973Y108 | 5,233,989 | $132.2M | 3.07% |
| 10 | CENTESSA PHARMACEUTICALS | CNTA | 9,681,818 | $109.4M | 2.54% |
| 11 | IMMUNOCORE | IMCR | 1,506,684 | $97.9M | 2.27% |
| 12 | HUTCHMED | HMDCF | 4,000,000 | $67.2M | 1.56% |
| 13 | BLEND LABS | BLND | 19,132,440 | $62.2M | 1.44% |
| 14 | ROYALTY PHARMA | RPRX | 1,500,000 | $45.6M | 1.06% |
| 15 | MOBILEYE | MBLY | 1,194,839 | $38.4M | 0.89% |
| 16 | RISKIFIED | RSKD | 5,324,998 | $28.8M | 0.67% |
| 17 | THIRD HARMONIC BIO | 88427A107 | 2,958,762 | $27.9M | 0.65% |
| 18 | ACELYRIN | 00445A100 | 2,889,668 | $19.5M | 0.45% |
| 19 | OPENDOOR | OPENZ | 6,321,519 | $19.2M | 0.44% |
| 20 | WISH | LOGC | 609,616 | $3.5M | 0.08% |
| 21 | GROVE COLLABORATIVE | GROVW | 936,020 | $1.6M | 0.04% |
| 22 | ADAGENE | ADAG | 264,000 | $739,200 | 0.02% |